Critical Care Diagnostics Market - Forecasts from 2019 to 2024

November 2019 | 105 pages | ID: CA94D011A9A2EN
Knowledge Sourcing Intelligence LLP

Abstracts

The critical care diagnostics market is expected to reach $20.603 billion by 2024 from $17.238 billion in 2018 growing at a CAGR of 3.02%. Critical care diagnostics is performed for a critically ill or injured patient or terminally ill patients dealing with life-threatening conditions requiring sophisticated invasive/non-invasive monitoring devices. It deals with the specialized care and diagnosis of life-threatening diseases in patients. These tests enable physicians to rapidly and accurately diagnose the disease and react immediately for proper treatment without any delay. Examples of critical care diagnostics include cancer biomarker test, cardiac markers diagnostics, drug abuse, pathogens screening, cholesterol screening etc. The market is estimated to show a robust growth during the given forecast period. The rise in the market may be attributed to the rising prevalence of the chronic diseases such as cardiac diseases and cancer. Also rising adoption of the critical care diagnostics by the physicians for the quick and accurate diagnosis of the life threatening disease will further augment the market growth during the forecast period. However, high cost of such equipments and lack of skilled professionals might hamper the market growth during the given time frame.

The Critical care diagnostics Market – Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by application, end users, and geography.

The critical care diagnostics market has been segmented based on application, end users, and geography. By application, the market has been segmented as haematology, cardiac and lipid testing, coagulation testing, microbial and infectious disease testing and others. By end users, the market has been segmented as diagnostic canters, research laboratories, home care settings and others.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 16 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in critical care diagnostics market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in critical care diagnostics market.

Segmentation

The critical care diagnostics market has been segmented by application, end users and geography.

• By Application
• Haematology
• Cardiac and lipid testing
• Coagulation testing
• Microbial and infectious disease testing
• Others
• By End Users
• Diagnostic Centers
• Research Laboratories
• Home Care Settings
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

'The report will be delivered in 3 working days.'

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Market Segmentation

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
  4.3.1. Bargaining Power of Suppliers
  4.3.2. Bargaining Power of Buyers
  4.3.3. Threat of New Entrants
  4.3.4. Threat of Substitutes
  4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. CRITICAL CARE DIAGNOSTICS MARKET ANALYSIS, BY APPLICATION

5.1. Introduction
5.2. Haematology
5.3. Cardiac and lipid testing
5.4. Coagulation testing
5.5. Microbial and infectious disease testing
5.6. Others

6. CRITICAL CARE DIAGNOSTICS MARKET ANALYSIS, BY END USERS

6.1. Introduction
6.2. Diagnostic Centers
6.3. Research Laboratories
6.4. Home Care Settings
6.5. Others

7. CRITICAL CARE DIAGNOSTICS MARKET ANALYSIS, BY GEOGRAPHY

7.1. Introduction
7.2. North America
  7.2.1. North America Critical Care Diagnostics Market, By Application, 2018 to 2024
  7.2.2. North America Critical Care Diagnostics Market, By End Users, 2018 to 2024
  7.2.3. By Country
    7.2.3.1. United States
      7.2.3.1.1. By Application
      7.2.3.1.2. By End Users
    7.2.3.2. Canada
      7.2.3.2.1. By Application
      7.2.3.2.2. By End Users
    7.2.3.3. Mexico
      7.2.3.3.1. By Application
      7.2.3.3.2. By End Users
7.3. South America
  7.3.1. South America Critical Care Diagnostics Market, By Application, 2018 to 2024
  7.3.2. South America Critical Care Diagnostics Market, By End Users, 2018 to 2024
  7.3.3. By Country
    7.3.3.1. Brazil
      7.3.3.1.1. By Application
      7.3.3.1.2. By End Users
    7.3.3.2. Argentina
      7.3.3.2.1. By Application
      7.3.3.2.2. By End Users
    7.3.3.3. Others
7.4. Europe
  7.4.1. Europe Critical Care Diagnostics Market, By Application, 2018 to 2024
  7.4.2. Europe Critical Care Diagnostics Market, By End Users, 2018 to 2024
  7.4.3. By Country
    7.4.3.1. Germany
      7.4.3.1.1. By Application
      7.4.3.1.2. By End Users
    7.4.3.2. France
      7.4.3.2.1. By Application
      7.4.3.2.2. By End Users
    7.4.3.3. United Kingdom
      7.4.3.3.1. By Application
      7.4.3.3.2. By End Users
    7.4.3.4. Italy
      7.4.3.4.1. By Application
      7.4.3.4.2. By End Users
    7.4.3.5. Others
7.5. Middle East and Africa
  7.5.1. Middle East and Africa Critical Care Diagnostics Market, By Application, 2018 to 2024
  7.5.2. Middle East and Africa Critical Care Diagnostics Market, By End Users, 2018 to 2024
  7.5.3. By Country
    7.5.3.1. Saudi Arabia
      7.5.3.1.1. By Application
      7.5.3.1.2. By End Users
    7.5.3.2. Israel
      7.5.3.2.1. By Application
      7.5.3.2.2. By End Users
    7.5.3.3. Others
7.6. Asia Pacific
  7.6.1. Asia Pacific Critical Care Diagnostics Market, By Application, 2018 to 2024
  7.6.2. Asia Pacific Critical Care Diagnostics Market, By End Users, 2018 to 2024
  7.6.3. By Country
    7.6.3.1. China
      7.6.3.1.1. By Application
      7.6.3.1.2. By End Users
    7.6.3.2. Japan
      7.6.3.2.1. By Application
      7.6.3.2.2. By End Users
    7.6.3.3. South Korea
      7.6.3.3.1. By Application
      7.6.3.3.2. By End Users
    7.6.3.4. India
      7.6.3.4.1. By Application
      7.6.3.4.2. By End Users
    7.6.3.5. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. Abbott
9.2. bioM?rieux SA
9.3. Danaher
9.4. Werfen Australia
9.5. Radiometer Medical ApS
9.6. Roche Diagnostics
9.7. Trivitron Healthcare
9.8. Siemens Healthcare GmbH

10. APPENDIX